Home  >  News
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
Technology + Font Resize -

Medidata rated pharma industry’s preferred provider of electronic data capture solutions: Report by Industry Standard Research

New York
Saturday, September 16, 2023, 13:00 Hrs  [IST]

Medidata, a Dassault Systèmes company, was rated the pharmaceutical industry’s preferred provider of electronic data capture (EDC) solutions in a new report by Industry Standard Research. This report also identified Medidata’s Rave EDC as the number one most recently used EDC system across the industry.

“We understand that for our customers and their patients, a robust, secure, and flexible EDC system is the cornerstone of a successful clinical trial,” says Wayne Walker, senior vice president, Rave Platform Technology, Medidata. “This recognition reinforces our belief that we have the groundbreaking technological solutions and expertise needed to meet our clients’ evolving needs.”

The EDC Benchmarking and Market Dynamics report surveyed 114 respondents on a range of topics, including EDC provider performance, EDC selection criteria, and EDC trends. Respondents from North America, Europe, and Asia selected Rave EDC as the most preferred solution based on the ease of use for sites, sponsors, and contract research organizations (CROs), scalability, real-time data access, capability for mid-study changes, and technical support and training.

Leveraging tools like EDC help set the pace and determine the success of an entire study.  Customers are looking for clinical trial technology solutions that are flexible and scalable and provide data confidence as a study progresses. Ultimately, a robust EDC benefits patients by  accelerating promising drug development and bringing new medicines to market more quickly and efficiently.

Medidata is a pioneer of EDC and a leader in the industry. The Medidata Platform, the company’s unified life sciences platform, which includes Rave EDC, connects patients, sites, sponsors, and partners in a secure and scalable cloud environment to bring life changing treatments to those who need them most.

Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. With over 20 years of groundbreaking technological innovation across more than 30,000 trials and 9 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across 2,100+ customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster.

Dassault Systèmes, the 3DEXPERIENCE company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable.


* Name :     
* Email :    
  Website :  
Pharma live expo
Copyright © 2023 Saffron Media Pvt. Ltd |